Ally Financial’s Thermo Fisher Scientific TMO Stock Holding History

Ally Financial’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.41M	Buy	11,000 +9,000	+450%	+$4.88M	0.67%	36
2025 Q4	$1.16M	Sell	2,000 -21,500	-91%	-$12.2M	0.14%	97
2025 Q3	$11.4M	Buy	23,500 +4,000	+21%	+$1.86M	1.41%	12
2025 Q2	$7.91M	Buy	19,500 +10,500	+117%	+$4.39M	0.89%	22
2025 Q1	$4.48M	Buy	9,000 +1,000	+13%	+$542K	0.5%	38
2024 Q4	$4.16M	Buy	8,000 +4,300	+116%	+$2.36M	0.51%	37
2024 Q3	$2.29M	Buy	3,700 +1,700	+85%	+$1.01M	0.28%	69
2024 Q2	$1.11M	Buy	+2,000	New	+$1.15M	0.14%	98
2024 Q1	–	Sell	-7,000	Closed	-$3.72M	–	119
2023 Q4	$3.72M	Buy	7,000 +1,000	+17%	+$484K	0.49%	51
2023 Q3	$3.04M	Buy	6,000 +3,100	+107%	+$1.65M	0.45%	59
2023 Q2	$1.51M	Hold	2,900	–	–	0.21%	78
2023 Q1	$1.67M	Hold	2,900	–	–	0.25%	67
2022 Q4	$1.6M	Hold	2,900	–	–	0.25%	76
2022 Q3	$1.47M	Hold	2,900	–	–	0.24%	80
2022 Q2	$1.58M	Buy	2,900 +900	+45%	+$495K	0.21%	84
2022 Q1	$1.18M	Buy	+2,000	New	+$1.15M	0.14%	100
2021 Q3	–	Sell	-10,000	Closed	-$5.04M	–	137
2021 Q2	$5.04M	Buy	10,000 +2,000	+25%	+$944K	0.5%	62
2021 Q1	$3.65M	Buy	8,000 +6,000	+300%	+$2.86M	0.35%	69
2020 Q4	$932K	Buy	+2,000	New	+$938K	0.09%	115
2020 Q2	–	Sell	-12,000	Closed	-$3.4M	–	130
2020 Q1	$3.4M	Buy	12,000 +7,000	+140%	+$2.21M	0.36%	56
2019 Q4	$1.62M	Hold	5,000	–	–	0.27%	85
2019 Q3	$1.46M	Buy	+5,000	New	+$1.43M	0.26%	81
2019 Q1	–	Sell	-5,000	Closed	-$1.12M	–	130
2018 Q4	$1.12M	Buy	+5,000	New	+$1.17M	0.15%	102
2018 Q3	–	Sell	-5,000	Closed	-$1.04M	–	130
2018 Q2	$1.04M	Hold	5,000	–	–	0.2%	98
2018 Q1	$1.03M	Buy	5,000 +1,500	+43%	+$315K	0.15%	112
2017 Q4	$665K	Sell	3,500 -1,500	-30%	-$287K	0.13%	108
2017 Q3	$946K	Buy	+5,000	New	+$906K	0.18%	102
2017 Q2	–	Sell	-25,000	Closed	-$3.84M	–	123
2017 Q1	$3.84M	Buy	25,000 +7,000	+39%	+$1.07M	0.87%	36
2016 Q4	$2.54M	Buy	18,000 +11,000	+157%	+$1.62M	0.43%	63
2016 Q3	$1.11M	Buy	+7,000	New	+$1.08M	0.2%	95
2016 Q2	–	Sell	-15,000	Closed	-$2.12M	–	127
2016 Q1	$2.12M	Buy	+15,000	New	+$2.01M	0.3%	98
2015 Q4	–	Sell	-45,000	Closed	-$5.5M	–	139
2015 Q3	$5.5M	Hold	45,000	–	–	0.56%	41
2015 Q2	$5.84M	Hold	45,000	–	–	0.59%	40
2015 Q1	$6.04M	Hold	45,000	–	–	0.63%	48
2014 Q4	$5.64M	Buy	45,000 +15,000	+50%	+$1.82M	0.62%	50
2014 Q3	$3.65M	Buy	30,000 +8,000	+36%	+$973K	0.5%	69
2014 Q2	$2.6M	Buy	+22,000	New	+$2.59M	0.31%	105
2014 Q1	–	Sell	-55,000	Closed	-$6.12M	–	154
2013 Q4	$6.12M	Hold	55,000	–	–	0.65%	54
2013 Q3	$5.07M	Buy	55,000 +10,000	+22%	+$904K	0.55%	67
2013 Q2	$3.81M	Buy	+45,000	New	+$3.75M	0.37%	92

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ally Financial's TMO Position: Q1 2026 in Review

Ally Financial increased its Thermo Fisher Scientific (TMO) stake by 450% in Q1 2026, buying an estimated $4.88M and bringing the position to 11,000 shares worth $5.41M. The position accounts for 0.67% of the portfolio, ranked #36.

Ally Financial first reported a position in TMO in Q2 2013 and has held it in 40 quarters since. The position peaked at $11.4M in Q3 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Ally Financial held 11,000 shares of Thermo Fisher Scientific worth $5.41M as of Q1 2026.
Ally Financial bought 9,000 Thermo Fisher Scientific shares in Q1 2026, an estimated $4.88M.
Thermo Fisher Scientific made up 0.67% of Ally Financial's portfolio in Q1 2026, its #36 holding.
Ally Financial first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 40 quarters since.
Ally Financial's Thermo Fisher Scientific position peaked at $11.4M in Q3 2025.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Ally Financial's 13F filing for Q1 2026, filed 12 May 2026.